The type 1 insulin-like growth factor receptor (IGF-IR) is known to protect cells from a variety of apoptotic injuries. In several instances, the anti-apoptotic eect of the wild type IGF-IR is more evident under conditions of anchorage-independence than in cells in monolayer cultures. We have investigated IGF-IR signaling in cells in anoikis, a form of apoptosis that occurs when cells are denied attachment to the extra-cellular matrix. IGF-I protects mouse embryo ®broblasts (MEF) from anoikis caused by withdrawal of growth factors. Survival is dependent on the concentration of IGF-I and a sucient number of functional IGF-I receptors. In this model, IGF-I protection correlates best with ras activation and cell-to-cell aggregation, while PI3-kinase, Akt and MAP kinases seem to play a lesser, alternative role.
Introduction
Untransformed mammalian cells are dependent on adhesion to a substratum, usually referred to as the extra-cellular matrix (ECM) for survival. When the cells are detached from the ECM, they undergo programmed cell death, which is often referred to as anoikis (Frisch and Francis, 1994; Day et al., 1997; Khwaja et al., 1997) . On the contrary, transformed cells are generally capable of growing in the absence of contact with the ECM, a property that is usually referred to as anchorage-independence (Macpherson and Montagnier, 1964) . The ability of tumor cells to grow in the absence of contact with the ECM should not be just considered as an artifact of cells in culture: anchorage independence correlates quite well with tumorigenicity (Aaronson and Todaro, 1968) , and is probably the property that allows tumor cells in the animal (including man) to in®ltrate surrounding tissues (local recurrences) and to establish distant metastases.
The type 1 insulin-like growth factor receptor (IGF-IR) activated by its ligands is emerging as a powerful inhibitor of apoptosis induced by a variety of agents. Thus, addition of IGF-I inhibits apoptosis induced by interleukin 3 withdrawal (McCubrey et al., 1991; Rodriguez-Tarduchy et al., 1992) , c-myc overexpression (Harrington et al., 1994) , interleukin-1b converting enzyme proteases expression (Jung et al., 1996) , serum withdrawal , anticancer drugs (Dunn et al., 1997) , and transforming growth factor b1 (Hsing et al., 1996) . An overexpressed and activated IGF-IR protects cells from apoptosis induced by a variety of agents, including etoposide (Sell et al., 1995) , interleukin 3 withdrawal (McCubrey et al., 1991; O'Connor et al., 1997; Prisco et al., 1997) , osmotic shock (Singleton et al., 1996b) , tumor necrosis factor a , p53 , ionizing and non-ionizing radiations (Kulik et al., 1997; Turner et al., 1997) and Okadaic acid . Conversely, impairment of the IGF-IR function, either by antisense strategies (Resnico et al., 1994a,b; Shapiro et al., 1994; Valentinis and Baserga 1996; Lee et al., 1996; Pass et al., 1996) , or by dominant negative mutants (Prager et al., 1994; D'Ambrosio et al., 1996) or by triple-helix formation (Rininsland et al., 1997) causes apoptosis of tumor cells in vivo and/or abrogation of tumorigenesis and metastases (Long et al., 1995; Burfeind et al., 1996; Dunn et al., 1998) . The variety of the procedures used to induce apoptosis suggests that the overexpressed wild type IGF-IR may have a widespread anti-apoptotic eect. In fact, Evan and collaborators have suggested that only Bcl-2 and the IGF-IR truly decrease the probability of apoptosis, whereas other procedures may inhibit the apoptotic pathway(s), without actually preventing cell death.
While tumor cells can grow in the absence of contact with the ECM, they also undergo apoptosis if their anchorage independence is perturbed by agents that little aect their growth in monolayer (Rak et al., 1995; Lebowitz et al., 1997; Baserga 1997) . The antiapoptotic eect of the activated IGF-IR is consistently more dramatic under anchorage-independence conditions, than on cells in monolayer cultures (Resnico et al., 1995a,b; D'Ambrosio et al., 1996) . However, if one wishes to study the biochemical or molecular mechanisms involved in the susceptibility of cells to apoptosis under anchorage-independence conditions, the classical method for testing anchorage independence, colony formation in soft agar (Macpherson and Montagnier, 1964) , has obvious drawbacks. For this reason, alternative methods have been recently proposed, by Assoian and co-workers (Guadagno and Assoian, 1991) on agarose-coated plates, and by several groups (Frisch and Francis, 1994; Kuzumaki et al., 1996; Kawada et al., 1997; Lebowitz et al., 1997) on polyhydroxyethylmethacrylate (polyHEMA) coated plates, a method originally proposed by Folkman and Moscona (1978) . In this latter test, the cells are released from their attachment to the ECM and are placed under conditions that deny them adhesion to a substratum. This assay has shown that epithelial cells undergo apoptosis, referred to as anoikis, even in 10% serum; ®broblasts are more resistant to apoptosis under the same conditions. In a previous paper from our laboratory , we reported that IGF-I could protect MEF from anoikis and that, under the conditions we used, anoikis was due to apoptosis, as demonstrated by three dierent methods.
In the following experiments, we wished to analyse the mechanism(s) by which the activated IGF-IR protects MEF from apoptosis when the cells are denied attachment to the ECM (anoikis). As shown here, even ®broblasts undergo anoikis if they are seeded in suspension cultures in serum free medium (SFM). The addition of IGF-I to SFM protects cells from anoikis. Survival under these conditions depends on the concentration of IGF-I, and correlates with the number of functional IGF-IR, ras activation, and the formation of aggregates in culture (cell-to-cell adhesion). At least in this modality of apoptosis, phosphatidylinositol (PI)-3-kinase, the serine/threonine kinase Akt, and the MAP kinases, all of which are certainly involved in IGF-IR anti-apoptotic signaling (Kennedy et al., 1997; Khwaja et al., 1997; Kulik et al., 1997) , seem to play a lesser, alternative role. Finally, an activated ras and Bcl-2 can completely replace the IGF-IR in protecting ®broblasts from anoikis.
Results
Unless otherwise noted, all the experiments described below were done with cells that were made quiescent in SFM for 48 h and detached from monolayers by the use of Versene (see Materials and methods), before seeding on polyHEMA-coated dishes. In preliminary experiments (not shown), we had observed that detachment of cells by trypsinization (as it is usually done also in our laboratory) caused the results to be somewhat erratic, probably due to the fact that trypsinization, even modest, induces partial breakdown of the extracellular part of growth factor receptors (Clark et al., 1991) . p6 cells (mouse embryo ®broblasts that over-express the human IGF-IR) were chosen for the initial experiments, because they are known to form colonies in soft agar very eciently (Pietrzkowski et al., 1992) , and to grow in anchorageindependent conditions in vivo . For clarity, we are giving, in the subsequent pages, representative experiments, but the experiments were repeated several times, and also at dierent concentrations of cells.
Survival of p6 cells in polyHEMA-coated dishes
When p6 cells are seeded on regular culture dishes, they survive even in SFM, and they grow if stimulated with either IGF-I or 10% serum (Pietrzkowski et al., 1992) . We have con®rmed these ®ndings in Figure 1 . In monolayer cultures (a), there is always a slight decrease in the cell number in the ®rst 5 h, in respect to the number of cells plated, as it regularly occurs when most cells are plated on culture dishes. After 5 h, however, the number of cells in SFM remains constant, and increases when the SFM is supplemented either with IGF-I or serum.
In a previous paper , we reported that p6 cells in SFM in polyHEMA plates, died by apoptosis, as shown by three dierent methods: FACS analysis, TUNEL assay, and DNA laddering. p6 cells survived if the medium was supplemented with IGF-I. In addition, both FACS analysis and Brdu labeling showed that p6 cells in polyHEMA plates in SFM supplemented with IGF-I, did not divide, and did not even enter S phase . This method, therefore, oers the possibility of studying the mechanism(s) by which IGF-I promotes survival, independently of its mitogenic eect. In 10% serum, p6 cells in suspension incorporated Brdu and grew in number.
These ®ndings are con®rmed and extended in Figure  1b . When p6 cells are seeded on polyHEMA-coated dishes, they survive in 10% serum or IGF-I (50 ng/ml), but they die in SFM, con®rming once more that the activated IGF-IR plays an important role in the survival of cells that are in anchorage-independence (Baserga et al., 1997; Baserga, 1997) . These experiments were repeated several times by dierent operators. At variance with another report (McGill et al., 1997) , under the conditions we used, and with these cells, seeding density in polyHEMA plates did not aect survival. In some of the following ®gures, the results in 10% serum are omitted, because MEF in polyHEMAcoated dishes, in 10% serum, invariably survive.
Survival is dependent on concentration of IGF-I p6 cells were seeded in polyHEMA plates as in the previous experiment, in SFM or in SFM supplemented with increasing concentrations of IGF-I. The cell number was determined after 24 h. Figure 2a shows that as little as 2.5 ng/ml of IGF-I already reduces the extent of cell death; at 5 ng/ml, there is almost complete protection, and the same result is obtained up to a concentration of 20 ng/ml. Above 20 ng/ml (Figure 2a) there is a modest increase in cell number, which was not always reproducible, even with p6 cells. With the other cell lines we could never observe even a modest increase in cell number, and for this reason, to insure a vigorous response to IGF-I, in subsequent experiments, we have used a concentration of 50 ng/ml.
Survival is also dependent on IGF-I receptor levels and function
For these experiments, we used R508 and R600 cells , that are R-cells stably transfected with a human IGF-IR cDNA, and express 15610 3 and 30610 3 IGF-IRs per cell, respectively (see also Materials and methods). R-cells are MEF with a targeted disruption of the IGF-IR genes (Sell et al., 1993 . R508 cells, plated on culture dishes, survive but do not grow in SFM supplemented with IGF-I (up to 100 ng/ml), do not form colonies in soft agar , and are sensitive to low concentrations of Okadaic acid . On the contrary, R600 cells grow in SFM supplemented solely with IGF-I, form colonies in soft agar and are resistant to okadaic acid-induced apoptosis . Figure 2b shows that R508 cells in polyHEMA plates die even when the SFM is supplemented with IGF-I (50 ng/ml), although the addition of the ligand has a modest protective eect (slight increase in survival). R600 cells, instead, die in SFM, but survive when IGF-I is added to the medium, almost as well as p6 cells, which have been added to the panel for a comparison. These experiments show that the number of functional IGF-IRs is crucial in protecting MEF from anoikis induced by growth factor withdrawal.
To con®rm that the survival of MEF in polyHEMA coated dishes depends on a functional IGF-IR, we used R-/KA cells, that are also derived from R-cells, but express a human IGF-IR with a mutation at the ATPbinding site, lysine K1003 (Kato et al., 1993; Coppola et al., 1994) . These cells express, like p6 cells, several hundred thousands receptors per cell, and grow very well in 10% serum, in monolayer cultures . When R-/KA cells are seeded in suspension, they die, not only in SFM, but also in SFM supplemented with 50 ng/ml of IGF-I ( Figure 2b ). There is in fact no signi®cant dierence in survival under the two conditions.
PI3-Kinase activity of cells in suspension
PI3-kinase activity was determined as described in Materials and methods. A representative experiment is shown in Figure 3a , but this experiment was repeated three times with the same results. In some experiments, total PI3-kinase activity was determined: the results were the same as in Figure 3a . We are showing only the results with R508 (not protected from anoikis) and R600 cells (protected), but similar results were also obtained with p6 cells. The radioactive spots were counted in a liquid scintillation counter (not shown). PI3-kinase activity was increased by IGF-I whether the cells were cultured in monolayers or on polyHEMAcoated dishes, but the increase was observed whether the cells were protected from anoikis (p6 or R600 cells) or not (R508 cells).
Phosphorylation of MAP kinase
We also determined the activation of MAP kinase, using an antibody that speci®cally detects a phosphorylated MAP kinase (see Materials and methods). This antibody detects both 42 and 44 kDa MAP kinase, as con®rmed in our Figure 3b . MAP kinase phosphorylation increases sharply by 10 min after addition of IGF-I, and this is true both in monolayers and in suspension, and for all three cell lines. There was no appreciable dierence between R600 and R508 cells, despite the fact that only the former are protected by IGF-I in polyHEMA-coated dishes.
Akt and IGF-I protection from anoikis
Several reports have indicated a relationship between the serine/threonine kinase Akt (also known as PKB) and IGF-I-mediated protection from apoptosis (Kennedy et al., 1997; Kulik et al., 1997; . To test the role of Akt in MEF anoikis, we transfected R508 cells (that die on polyHEMA plates even in the presence of IGF-I) with a plasmid expressing v-Akt, and p6 cells (that survive) with a plasmid expressing the kinase-mutant of c-Akt. Figure  4b , shows the levels of expression of v-Akt (lanes 2 and 3) and kinase-Akt (lanes 5 and 6) in selected clones of R508 and p6 cells, respectively, and in control, untransfected cells (lanes 1 and 4). Figure 4a , shows that v-Akt does not protect R508 cells from apoptosis in SFM or in SFM supplemented with IGF-I (lanes 2 and 3). Expression of the dominant negative kinasemutant of c-Akt has no eect on the survival of p6 cells, when the SFM is supplemented with IGF-I (lanes 5 and 6). The v-Akt and kinase-mutant Akt used in these experiments were the same plasmids that exerted protection from apoptosis, or accelerated apoptosis, respectively, in serum-deprived Rat-1 cells (Kennedy et al., 1997) . We also determined the Akt kinase activity in these cellular clones. Figure 4c shows that Akt activity in R508 cells increases after stimulation with IGF-I (1st bar); in R508 cells stably transfected with vAkt, IGF-I does not cause any increase (2nd bar), because the basal level was already 60% higher than in untransfected R508 cells (middle bar). On the contrary, the Kinase-mutant of Akt causes a marked decrease in Akt kinase activity in p6 cells: the two last bars are, respectively, untransfected p6 cells and p6 cells transfected with the kinase mutant of Akt. IGF-I causes a marked increase in Akt kinase activity in p6 cells, but not in the transfected cells (p6/Akt-Ki), where the activity actually decreases after IGF-I.
Eect of PI3-kinase inhibitors
The experiments just described indicate that PI3-kinase activity and MAPK activity do not strictly correlate with survival in this model of apoptosis; their increase may be necessary for survival but not sucient. The same can be said of Akt. A number of objections could be raised. For instance, it could be objected that a single measurement in time of PI3-kinase activity is not representative of the whole process. Since it would be impractical to measure PI3-kinase activity throughout the experiment, we used two inhibitors of PI3-kinase activity, wortmannin and LY294002 (Kennedy et al., 1997) . Figure 5 shows that these two inhibitors, even at quite high concentrations, do not interfere with the IGF-I protection of p6 cells from anoikis. As one of the controls for this experiment, we used MEF, that survive in polyHEMA plates in 10% serum. We therefore used R-cells , that have no IGF-IR, seeded them in 10% serum in polyHEMA plates and treated then with the PI3-kinase inhibitors. Figure 5 shows that these inhibitors drastically decrease the survival of R-cells in 10% serum, demonstrating, at the same time, that the concentrations of inhibitors used were sucient for inhibition and that protection of cells in 10% serum follow the known pathway, that involves PI3-kinase (see Introduction).
Since IGF-I-treated p6 cells survive in polyHEMA plates even in the presence of high concentrations of PI3-kinase inhibitors, we then asked whether these inhibitors would aect the activation of Akt. For this experiment, the cells were treated or not with the inhibitor LY294002 at the concentration of 50 mM. Akt activation was measured with an antibody that recognizes the phosphorylated protein (see Materials and methods). IGF-I activates Akt in p6 cells ( Figure   Figure 3 (a) PI3-kinase activity in cells in monolayers and on polyHEMA plates. R508 or R600 cells were plated either on regular culture dishes (attached) or on polyHEMA coated dishes (suspension). One hour after plating, they were left unstimulated (7) or were stimulated with 50 ng/ml of IGF-I for 10 min (+). PI3-kinase activity was determined as described in Materials and methods. PIP, phosphoinositol phosphate; Ori., Origin. (b) MAP kinase activity of mouse embryo ®broblasts after IGF-I stimulation. Cells were prepared and seeded as described in Materials and methods, where is also given the methodology for the detection of phosphorylated MAP kinases. The lysates were prepared from unstimulated cells (time 0) or from cells stimulated with IGF-I (50 ng/ml) at the indicated times (in minutes). In the ®rst two panels, the response of p6 cells on polyHEMA coated dishes, 10 min after IGF-I (last lane) is given for comparison 6, lane 5), con®rming the numerous reports in the literature. However, when the cells are treated with LY294002, activation of Akt is abrogated (Figure 6 , lane 6); yet, as reported above, the p6 cells survive the treatment with the PI3-kinase inhibitor. The presence of 10% serum also induces Akt phosphorylation in Rcells (lane 2), which is inhibited by LY294002 (lane 3), but now the cells are not protected from apoptosis (Prisco et al., in press ). These results clearly point out that IGF-I and serum may have the same antiapoptotic pathway, but that the IGF-IR has in addition a second pathway, not shared with serum. Both cell lines were seeded in polyHEMA plates. p6 cells were incubated in SFM plus 50 ng/ml of IGF-I, while R-cells were in 10% serum, with or without the inhibitors at the concentrations indicated on the abscissa. The ordinate gives the percentage increase (or decrease) in cell number (over plating), as determined after 24 h incubation. The bars indicate standard deviations Figure 6 Eect of inhibitors of PI3-kinase on Akt activity. Cells were pre-treated with LY294002 (50 mM) and stimulated by either IGF-I or serum. Lysates were prepared, and phospho-Akt and amounts were determined as described in Materials and methods.
The lower panel shows that amounts of Akt in the lysates were essentially the same in all lanes.
The role of ras in protection from anoikis
Ras is known to protect cells from anoikis (Khwaja et al., 1997) , and we studied its role in our system by determining the GTP/GDP ratio in R508 and R600 cells, after stimulation with IGF-I. When both cell lines were kept in monolayers, IGF-I caused a sharp increase in ratio ( Figure 7a) ; however, in suspension, IGF-I caused an increase only in R600 cells. We then tested the ability of ras itself to protect R-cells from anoikis. For this purpose, we used a cell line, R-/ras, that are R-cells (no IGF-I receptors) over-expressing an activated ras . These cells, previously characterized as incapable of forming colonies in soft agar, survived very well, even in serum-free medium, when plated on polyHEMA plates (Figure 7b) , clearly con®rming the ability of an activated ras to protect MEF from anoikis.
Finally, we investigated the role of the Bcl-2 family of proteins in protection from anoikis. When R508 cells are stably transfected with a plasmid expressing Bcl-2 (see Materials and methods), they survive, even in SFM, and their survival increases with the addition of IGF-I (not shown).
Discussion
Our results can be summarized as follows: (1) IGF-I protects MEF from anoikis in SFM. The protective eect of IGF-I is concentration-dependent, requires a functional IGF-IR, and a sucient number of receptors; (2) IGF-I-mediated survival correlates with ras activation, and this correlation is further strengthened by the ®nding that R-cells stably transfected with an activated Ha-ras are fully protected from anoikis even in SFM; (3) while MEF in 10% serum seem to follow the generally accepted anti-apoptotic pathway (the PI3-kinase/Akt pathway), the IGF-IR can also use for protection from anoikis a second pathway that seems to be PI3-kinase-independent. This statement is based on the observation that inhibitors of PI3-kinase have no eect on IGF-I-mediated survival of MEF in suspension, even though they completely abrogate Akt activation and are active against MEF in 10% serum. To avoid any misunderstanding, we would like to emphasize that the present experiments are not contradicting the various reports that the PI3-kinase pathway (through Akt) plays a major role in the antiapoptotic eect of the IGF-IR. They simply show that, under certain conditions, the IGF-IR can use an alternative pathway; (4) survival under these conditions also correlates with the extent of cell aggregation ; and (5) ®nally (and not surprisingly), the Bcl-2 family of proteins can protect MEF from anoikis even in SFM.
One of the novel aspects of these investigations is the method we have used to study the anti-apoptotic eect of IGF-I and the activated IGF-IR. We have used an assay in which apoptosis is induced simply by placing the cells in SFM under conditions in which the cells are denied attachment to the ECM. This method has been recently used by a number of investigators (see Introduction), most of whom used epithelial cells, that undergo anoikis more readily (Frisch and Francis, 1994; Frisch et al., 1996; Khwaja et al., 1997) , even in 10% serum. These authors showed repeatedly that anoikis is based on apoptotic death of the cells, an we have con®rmed this ®nding in a previous paper . Fibroblasts in general are reported to survive in suspension cultures, when seeded in 10% serum (Frisch and Francis, 1994; McGill et al., this paper) , but in SFM they undergo anoikis. Addition of IGF-I protects MEF from anoikis, provided that a certain number of functional IGF-IR are present (this paper, and see also Reiss et al., 1998) . One advantage of this method is that the protective eect of IGF-I can be dissociated from its mitogenic eect. Although MEF seeded on polyHEMA plates survive when incubated with IGF-I, they do not divide and they do not even enter DNA synthesis . Thus, in this model, one can study the Our experiments show an interesting correlation between survival and certain events. For instance, activation of ras correlates with survival from anoikis, and, indeed, an activated ras replaces the activated IGF-IR to confer complete protection in SFM. This is in agreement with the ®ndings of Khwaja et al. (1997) on epithelial cells. These authors also showed that a dominant negative mutant of ras induced apoptosis. Another dierence we found between surviving cells and cells programmed to undergo anoikis was in the extent of the formation of aggregates , which is a measure of cell-to-cell adhesion. IGF-I has already been show to mediate cell-to-cell adhesion (Guvakova and Surmacz, 1997) , and to promote cell motility (Doerr and Jones, 1996; Dunn et al., 1998) . A correlation between formation of aggregates and survival was also reported by McGill et al. (1997) .
We have also obtained with this model some other interesting results, i.e. a lack of strict correlation with events that are known to play an important role in protection from apoptosis in general, and in IGF-IRmediated protection in particular. Thus, PI3-kinase activity increases in all cell lines after IGF-I stimulation, regardless of whether it is measured in cells in monolayers or cells in suspension, and regardless of whether the cells are programmed to undergo apoptosis or not. This increase in PI3-kinase activity is not incompatible with several reports linking the activation of PI3-kinase to the protective eect of the IGF-IR (Kulik et al., 1997; , but points out that it may not be sucient, or, alternatively, that the IGF-IR may use in this system a second pathway. We have measured both IRS-1 associated and total PI3-kinase activity, and the results were the same.
The same lack of correlation with IGF-I protection from apoptosis can be said of MAP kinase activation, as determined by its phosphorylation, and of Akt. These discrepancies require some explanations. Our ®ndings with MAP kinase activation are in sharp contrast to a previous report (Lin et al., 1997) , indicating that the activation of MAP kinase was abrogated in cells following removal from the ECM. This discrepancy may be largely due to dierent experimental procedures: in the previous report, cells were trypsinized and then kept in suspension for 30 min. In our experiments, cells were detached by Versene, since, as mentioned above, trypsinization is known to partially digest the extracellular portions of growth factor receptors (Clark et al., 1991) . Also at variance with other experimental situations, we found a lack of correlation with the serine/threonine kinase Akt, activation which has also been shown to be important in protection from apoptosis, including IGF-I mediated protection (Kennedy et al., 1997; Khwaja et al., 1997; Datta et al., 1997) . Khwaja et al. (1997) convincingly demonstrated in MDCK epithelial cells in suspension cultures that protection by ras was dependent on the activation of the PI3-kinase/Akt pathway. There are two major dierences between our model and that used by Khwaja et al. (1997) . They used epithelial cells, that die by anoikis even in 10% serum (the conditions used by these authors), and, of course, their anti-apoptotic agent was ras, which is known to activate the PI3-kinase/Akt pathway (Rodriguez-Viciana et al., 1994; Khwaja et al., 1997) . Still, in our model, ras is activated, and an activated Ha-ras is as eective as the IGF-IR in preventing anoikis in SFM.
More signi®cant, however, are our ®ndings with inhibitors of PI3-kinase activity. We have used both wortmannin and LY294002, essentially with the same results. Even at high concentrations, these inhibitors do not aect IGF-I-mediated survival of MEF in polyHEMA plates. At the same concentrations, these inhibitors completely abrogate Akt activation, and suppress survival mediated by 10% serum. The use of inhibitory drugs to test pathways has its pitfalls, since many`speci®c' drugs invariably turn out to inhibit other reactions. However, if an event (in this case, protection from apoptosis) is insensitive to high concentrations of PI3-kinase inhibitors, one has to conclude that PI3-kinase is not a requirement under those conditions, since these inhibitors may have other functions, but one thing they do is to inhibit PI3-kinase. It may objected that there may be PI3-kinases that are insensitive to these inhibitors: however, when the same inhibitors were tested on cells in 10% serum, they strongly inhibited the protective eect of serum. This is doubly signi®cant, because it con®rms that, in serum, MEF follow the generally accepted pathway (PI3-kinase-dependent) and that the IGF-IR is indeed using another pathway, which is not a replacement, but an alternative. In addition, these inhibitors abrogate insulin-mediated survival of MEF, which is dependent on the activation of IRS-1 (Prisco et al. in press) . Clearly, the IGF-IR can protect cells from apoptosis by a mechanism that is independent of the PI3-kinase/ Akt pathway, at least the most commonly studied PI3-kinases. An indirect con®rmation comes from the data of Dews et al. (1998) , showing that the IGF-IR can protect 32D cells from apoptosis; 32D cells have no IRS-1 or IRS-2, and therefore give undetectable levels of PI3-kinase activation, when tested in SFM with the appropriate growth factors. An additional pathway has also been suggested by other investigators (Zamorano et al., 1996; , while others still have reported forms of apoptosis that do not correlate with the activation of PI3-kinase (Gunn-Moore et al., 1997). Perhaps, the activation of the PI 3-kinase/Akt pathway is the usual pathway, but our results seem to indicate that, at least in the case of anoikis (and also in 32D cells), the IGF-IR can use another pathway. At this point, one can only speculate on the nature of this pathway. A possible clue is given by the report that 14.3.3 binds directly to the IGF-IR (Craparo et al., 1997) , at serine residues located in the C-terminus, between 1272 and 1283. According to Craparo et al. (1997), 14.3 .3 also binds to IRS-1, in fact, it may bind to IRS-1 more eectively than to the IGF-IR. IRS-1 activates PI3-ki, which activates Akt. In turn, in response to survival factors, including IGF-I (Datta et al., 1997) , the pro-apoptotic protein Bad is serine phosphorylated by Akt, is no longer capable to heterodimerize with Bcl-X L , binds instead to 14.3.3 and is thus inactivated as a cell death protein (Zha et al., 1996) . Perhaps, the IGF-IR can inactivate Bad, not only through Akt, but also through a direct eect on 14.3.3.
Two previous reports have appeared, indicating increased levels of expression of Bcl-x L in cells stimulated by IGF-I (Singleton et al., 1996a, Parrizas and . Bcl-x L is also regulated by adhesion to the substratum in keratinocytes (Rodeck et al., 1997) . We therefore checked in our model whether proteins of the Bcl-2 family may protect MEF from anoikis. Our results with 508 cells expressing Bcl-2 show that they protect, actually by-passing the requirement for IGF-I.
Because of the very close association between PI3-kinase and FAK (Rankin et al., 1996) , and because of the role of FAK in anoikis (Frisch et al., 1996) , we have also measured FAK phosphorylation in both p6 cells in monolayers and in suspension. FAK is eventually tyrosyl phosphorylated in surviving p6 cells seeded on polyHEMA plates , but this is a late event, and we interpreted it as being an eect rather than the cause of survival. Experiments to elucidate this delay response are presently in progress.
In conclusion, IGF-I and the IGF-IR are not necessary for survival of MEF in SFM in monolayer cultures, but are required to protect the same cells from anoikis. Our results dier slightly from those of other laboratories, indicating that deprivation of growth factors causes apoptosis even in monolayers (Harrington et al., 1994; . However, in the former case, growth factor deprivation was accompanied by the activation of c-myc, which was required to induce apoptosis. Dierences in the origin of the cell lines may account for the discrepancy with the latter case; our R-derived cells do very well in SFM in monolayers for at least 72 h. While we have con®rmed the activation, by IGF-I, of some of the previously reported pathways (especially PI3-kinase, Akt and MAP kinases), our experiments show that survival in the absence of ECM correlates best with ras activation (this paper) and cell aggregation . We would like to conclude that the IGF-IR, besides the generally accepted pathway of protection from apoptosis, has an alternative pathway, which is PI3-kinase/Akt-independent. It will be interesting to determine now whether this second pathway eventually connects (and, if so, at what point) with the classical anti-apoptotic pathway.
Materials and methods
Plasmids pcDNA3-Bcl-2 plasmid was used for the expression of human Bcl-2 protein (a kind gift of Dr Subrata, Kimmel Cancer Center, Philadelphia, PA, USA). pPDV6+ plasmid or pLHL4 plasmid (Gritz and Davies, 1983) were used to confer resistance to Puromycin or Hygromycin, respectively. pCDNA3.HT/Akt-K179M (kinase -) and pRSa/v-Akt (a kind gift of P Tsichlis and A Bellacosa, Fox Chase Cancer Center, Philadelphia, PA, USA) were used for the expression of Akt kinase negative, and constitutively activated Akt, respectively.
PolyHEMA
Petri dishes (Falcon) were coated with a ®lm of polyHEMA (Sigma), following the protocol reported by Folkman and Moscona (1978) . Brie¯y, a solution of 120 mg/ml of polyHEMA in 95% ethanol was mixed overnight, centrifuged at 2500 r.p.m. for 30 min to remove undissolved particles and diluted 1 : 10 with 95% ethanol. 0.95 ml per mm 2 were pipetted in Petri dishes of 35 mm or 100 mm diameter, and dishes were left to dry at room temperature. Before use, polyHEMA coated dishes were washed twice in PBS and once in Hank's.
Cell lines and transfection
p6 cells are Balb/c 3T3 MEF constitutively expressing a high level of wild type human IGF-IR (Pietrzkowski et al., 1992) . R-cells are MEF with targeted disruption of the IGF-IR (Sell et al., 1993) . From R-cells were derived the following three cell lines: R508, expressing 15610 3 human IGF-IR ; R600 cells, expressing 30610 3 IGF-IRs; and R-/KA expressing a high level of human IGF-IR with a point mutation in the ATP-binding site . R508 cells were co-transfected using the Transfectam Reagent (Promega) with the pcDNA3-Bcl-2 plasmid or the pRSa/v-Akt plasmid and the pPDV6+ plasmid at a molar ratio 20 : 1. Clones were selected in 3 mg/ml of Puromycin. p6 cells were co-transfected with the Kinase-negative Aktexpressing plasmids and the pLHL4 plasmid. Clones were selected in 200 mg/ml of Hygromycin B.
R-/ras cells are R-cells stably transfected with a Ha-ras plasmid, containing a genomic fragment of the human Ha-ras gene derived from T24 bladder carcinoma cells (codon 12 mutation). These cells do not form colonies in soft agar.
Cell culture
Cells were made quiescent on regular culture plates in SFM (DMEM supplemented with 0.1% bovine serum albumin and 50 mg/ml transferrin) for 48 h and then a single cell suspension was obtained by using Versene solution only (no trypsin). Unless otherwise indicated, cells were seeded on polyHEMA coated dishes (0.5 ± 1610 5 /ml) or in regular culture plates (7610 4 /cm 2 ) in SFM, with or without IGF-1 (GIBCO) at the concentrations indicated in the dierent experiments, or with the addition of 10% serum, and incubated at 378C. At the indicated times cells were collected, washed in versene, resuspended in trypsin and counted using a hemocytometer.
PI3-kinase assay
Cells on culture plates or polyHEMA coated dishes (1 h after plating), were stimulated with 50 ng/ml of IGF-1 for 10 min, and lysed. 300 mg of proteins were immunoprecipitated with a polyclonal anti-insulin receptor substrate 1 (IRS-1) antibody and the PI3-kinase activity associated with IRS-1 was determined following the protocol recommended by the manufacturer of the antibody (UBI). Brie¯y, the immunoprecipitates were incubated in vitro with phosphatidylinositol and [g-32 P]ATP for 15 min at 378C, and the extracted radiolabeled lipids analysed by thin-layer chromatography. The products of the kinase reaction were visualized by autoradiography and quantitated by counting the radioactivity of excised spots in a scintillation counter.
Akt kinase assay
In vitro Akt kinase activity was determined in suspended cells in SFM or stimulated for 3 min with IGF-I (50 ng/ ml). Cells were collected, washed once with ice-cold PBS and lysed. Equal amount of proteins were immunoprecipitated with an anti-Rat Akt polyclonal antibody (Upstate Biotecnology, Lake Placid, NY, USA). Immunoprecipi-tated proteins were washed three times with lysis buer, once with kinase assay buer (20 mM HEPES, pH 7.4; 1 mM DTT; 10 mM MnCl 2 ; 10 mM MgCl 2 ) and resuspended in 20 ml of kinase assay buer containing 3.5 mM cold ATP, 5m Ci/sample of [g 32 P]ATP (3000 Ci/mmol), and 100 mg/ml of Histone H2B (Boehringer). The reaction was performed at room temperature and stopped after 20 min with 20 ml of loading buer. Samples were boiled for 5 min and the surnatant loaded in a 12% SDS-gel. Proteins were resolved by SDS ± PAGE, blotted on a nitrocellulose ®lter and radioactive Histone H2B was visualized by autoradiography. Radioactive bands were excised and radioactivity quantitated by scintillation counting.
In other experiments, detection of phosphorylated and total Akt was determined using the Phospho Plus AKT (Ser 473) Antibody Kit (New England Biolabs), according to the manufacturer's protocol.
MAP kinase activation
The level of MAP kinase activation was determined using a rabbit polyclonal antibody raised against the duallyphosphorylated Thr/Glu/Tyr region of the active form of the MAP kinase enzymes (Promega). 10 mg of cell lysates were resolved by SDS ± PAGE and electroblotted to a nitrocellulose ®lter. Immunoblotting and chemiluminescent detection were performed as described above.
Ras activation

IGF-I mediated p21
ras -GTP formation was determined incubating cell (in monolayer or suspension) in phosphate-free DMEM (GIBCO-BRL) in the presence of [ 32 P]orthophosphate (0.25 mCi/ml) for 3 h. After stimulation with IGF-I (50 ng/ml) for 15 min, cells were washed in PBS and lysed. GTP and GDP bound p21 ras were immunoprecipitated with agarose conjugated anti v-HRas monoclonal rat IgG (Ab-1, Calbiochem) for 2 h at 48C. Nucleotides were eluted by suspending immunoprecipitates in 20 ml of elution buer (10 mM HEPES; 2 mM DTT; 0.2% SDS; 500 mM GTP; 500 mM GDP) and heating at 908C for 3 min. GTP and GDP were resolved by thin layer chromatography on PEI cellulose sheets (JT Baker, Phillisburgh, NJ, USA). Radioactive bands corresponding to GTP and GDP were cut and measured by liquid scintillation counting. IGF-I mediated ras activation was expressed as increase of GTP/GDP+GTP ratio by IGF-I over SFM.
Western blotting
The expression of Bcl-2 or the Akt protein in Figure 4 was analysed by Western blotting. Cell lysates from cells exponentially growing were clari®ed by centrifugation and their protein concentration determined. Twenty mg of protein were resolved on a 4 ± 15% gel SDS ± PAGE and electroblotted to a nitrocellulose ®lter. The ®lters were immunoblotted with a monoclonal anti-human Bcl-2 antibody (sc-509, Santa Cruz Biotechnology) or a monoclonal antibody HA.11 (Babco), followed by antimouse horseradish peroxidase-conjugated antibody (Oncogene Science). Visualization of the immunocomplexes was obtained by the ECL detection system following the manufacturer's instruction (Amersham Corp.).
Chemicals
Wortmannin was purchased from Sigma Chemical Co. (St. Louis, MO, USA) and LY294002 from Biomol Res. Lab. (Plymouth Meeting, PA, USA). Both inhibitors were resuspended in dimethylsulfoxide (DMSO) at the concentrations indicated in Results.
Abbreviations ECM, extracellular matrix; FAK, focal adhesion kinase; IGF I, insulin-like growth factor I; IGF IR, type 1 insulinlike growth factor receptor; IRS-1 insulin receptor substrate 1; MEF, mouse embryo ®broblasts; PI, phophatidylinositol; PolyHEMA, polyhydroxyethylmethacrylate; SFM, serum free medium.
